Fatty acid niacin conjugates and their uses
AssigneeCatabasis Pharmaceuticals, Inc.
InventorsJill C. Milne, Michael R. Jirousek, Jean E. Bemis, Chi B. Vu, Amal Ting
Life of this patent
Estimating the term…
Abstract
The invention relates to fatty acid niacin conjugates; compositions comprising an effective amount of a fatty acid niacin conjugate; and methods for treating or preventing an metabolic disease comprising the administration of an effective amount of a fatty acid niacin conjugate.
Claims30
A molecular conjugate comprising a niacin covalently linked to a fatty acid, wherein the fatty acid is selected from the group consisting of omega-3 fatty acids and fatty acids that are metabolized in vivo to omega-3 fatty acids, wherein the niacin is not linked to the fatty acid through —OCH2O—, and the conjugate is capable of hydrolysis to produce free niacin and free fatty acid.
A compound of Formula II:
- or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, enantiomer or stereoisomer thereof;
- wherein
- R1, R2, and R3 are each independently selected from the group consisting of —H, -D, —Cl, —F, —CN, —NH2, —NH(C1-C3 alkyl), —N(C1-C3 alkyl)2, —NH(C(O)C1-C3 alkyl), —N(C(O)C1-C3 alkyl)2, —C(O)H, —C(O)C1-C3 alkyl, —C(O)OC1-C3 alkyl, —C(O)NH2, —C(O)NH(C1-C3 alkyl), —C(O)N(C1-C3 alkyl)2, —C1-C3 alkyl, —O—C1-C3 alkyl, —S(O)C1-C3 alkyl, and —S(O)2C1-C3 alkyl;
- W1 and W2 are each independently selected from null, O, S, NH, and NR;
- each a, b, c, and d is independently —H, -D, Halogen, —CH3, —OCH3, —OCF3, —OCH2CH3, or —C(O)OR, —O—Z, or benzyl, or two of a, b, c, and d can be taken together along with the single carbon to which they are bound to form a cycloalkyl or heterocycle;
- each n, o, p, and q is independently 0 or 1;
- each L is independently —O—, —S—, —S(O)—, —S(O)2—, —S—S—,
- each g is independently 2, 3 or 4;
- each h is independently 1, 2, 3 or 4;
- each m is independently 0, 1, 2, or 3;
- if m is more than 1, then L can be the same or different;
- each m1 is independently 0, 1, 2, or 3;
- k is 0, 1, 2, or 3;
- each R6 is independently H or C1-C6 alkyl, or both R6 groups, when taken together with the nitrogen to which they are attached, can form a heterocycle;
- each R7 is independently e, H or straight or branched C1-C10 alkyl which can be optionally substituted with OH, NH2, CO2R, CONH2, phenyl, C6H4OH, imidazole or arginine;
- each e is independently H or any one of the side chains of the naturally occurring amino acids;
- each R9 is independently —H, -D, C1-C4 alkyl, halogen, cyano, oxo, thiooxo, —OH, C(O)C1-C4 alkyl, O-aryl, O-benzyl, OC(O)C1-C4 alkyl, C1-C3 alkene, C1-C3 alkyne, C(O)C1-C4 alkyl, NH2, NH(C1-C3 alkyl), N(C1-C3 alkyl)2, NH(C(O)C1-C3 alkyl), N(C(O)C1-C3 alkyl)2, SH, S(C1-C3 alkyl), S(O)C1-C3 alkyl, S(O)2C1-C3 alkyl;
- each Z is independently —H, or
- with the proviso that there is at least one
- each r is independently 2, 3, or 7;
- each s is independently 3, 5, or 6;
- each t is independently 0 or 1;
- each v is independently 1, 2, or 6;
- R4 and R5 are each independently hydrogen, deuterium, —C1-C4 alkyl, -halogen, —OH, —C(O)C1-C4 alkyl, —O-aryl, —O-benzyl, —OC(O)C1-C4 alkyl, —C1-C3 alkene, —C1-C3 alkyne, —C(O)C1-C4 alkyl, —NH2, —NH(C1-C3 alkyl), —N(C1-C3 alkyl)2, —NH(C(O)C1-C3 alkyl), —N(C(O)C1-C3 alkyl)2, —SH, —S(C1-C3 alkyl), —S(O)C1-C3 alkyl, —S(O)2C1-C3 alkyl;
- and
- each R is independently —H or —C1-C3 alkyl;
- provided that
- when m, n, o, p, and q are each 0, W1 and W2 are each null, and Z is
- then t must be 0;
- and
- when each of m, n, o, p, and q is 0, and W1 and W2 are each null, then Z must not be
Dependencies are inferred from the claim text.